✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Biocon Ltd.

BIOCON

Market Cap
₹48,445 Cr.
P/E
47.81

Biocon Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
48,445 Cr
PE
PE
47.81
Prom Holding
Prom Holding
60.64 %
ROE (%)
ROE (%)
5.17
ROCE (%)
ROCE (%)
6.43
Div Yield (%)
Div Yield (%)
0.28
Sales
Sales
15,261 Cr
OPM (%)
OPM (%)
20.55 %
Debt to Equity
Debt to Equity
0.81
View more
Edit Ratio's
About
Biocon Limited is an innovation-led global biopharmaceuticals company that manufactures biotec… Read more
Low
291
52W Range
High
405
  • Biocon
  • Concord Biotech
  • Advanced Enzyme
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
1.52 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.27 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
4.21 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
1.04 %
(as of Nov 21)
Historic
Blood Related - Market Share
27 %
(as of Mar 19)
Source/Historic
CANMAb - Market Share
0.05 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    CANMAb
    Insugen
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Sobha Ltd.
    • Alkyl Amines Chemicals Ltd.
    • B.L. Kashyap and Sons Ltd.
    FAQs on Biocon Ltd. Business

    Biocon Limited is a global biopharmaceuticals company focusing on developing and manufacturing innovative biologics, biosimilars, and APIs for chronic conditions. They also have a pipeline of novel assets in immunotherapy.

    Biocon major competitors are Concord Biotech, Advanced Enzyme, Fermenta Biotech, Glenmark Pharma, Glaxosmithkline Phar, Alkem Laboratories, Ipca Laboratories.
    Market Cap of Biocon is ₹47,542 Crs.
    While the median market cap of its peers are ₹35,222 Crs.

    Biocon seems to be less financially stable compared to its competitors.
    Altman Z score of Biocon is 1.57 and is ranked 8 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
    Investor Presentation May Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Apr Jun Jul Sep Dec Jan Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
    Conference Call Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Biocon Ltd.
    Biocon Biologics Serum Lifesciences collaboration call notes - JST Investments
    View the discussion on ValuePickr
    Industrial Biotechnology - Insulin Production - NPTEL
    How Biocon produces Insulin using rDNA Technology - Bio Science
    Biocon - Viatris Takeover Primer - JST Investments
    Biocon Biologics - An effort to understand the biosimilar business - Dr Midhun
    Biotech to Billions: THINK BIG, NEVER GIVE UP & DISRUPT - G2G Ajay
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material